D-1213-2018 Class II Terminated
FDA drug recall D-1213-2018 was initiated by Hetero Labs Limited Unit V on Aug 20, 2018 and is designated Class II. Reason for recall: Discoloration: A complaint was received from a pharmacist for the presence of blue specks on tablets. The recall status is terminated (terminated Nov 5, 2021). Affected quantity: 98,016 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 3, 2018
- Initiation Date
- Aug 20, 2018
- Termination Date
- Nov 5, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 98,016 bottles
Product description
Montelukast Sodium Tablets, 10 mg*, 30-count bottles, Rx Only, By: Hetero, Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-726-30.
Reason for recall
Discoloration: A complaint was received from a pharmacist for the presence of blue specks on tablets.
Distribution pattern
Nationwide in the USA
Code information
Lot #: MON17355, Exp 12/19
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1213-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026